On December 28, 2017 Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on myelodysplastic syndromes (MDS), reported that it will present at Biotech Showcase taking place January 8-10 in San Francisco (Press release, Onconova, DEC 28, 2017, View Source [SID1234522785]). The Company’s CEO and President, Dr. Ramesh Kumar, will present and management will be available for one-on-one meetings.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Presentation Details:
Date: Tuesday, January 9th, 2018
Time: 2:00 pm PDT (5:00 pm EST)
Location: Franciscan Room B at the Hilton San Francisco Union Square, 333 O’Farrell Street – Ballroom Level
The presentation will be available on the Investors section of the Company’s website at: View Source